SEC Filing Summary: Mast Therapeutics, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Mast Therapeutics, Inc. (formerly ADVENTRX Pharmaceuticals, Inc.) on March 11, 2013. The report documents a corporate name change effective as of the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event and does not contain financial statements or performance data.
Material Changes
- Corporate Name Change: The registrant officially changed its name from ADVENTRX Pharmaceuticals, Inc. to Mast Therapeutics, Inc. on March 11, 2013.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document references a press release (Exhibit 99.1) for further details but does not include the text of that release.
Key Facts for Investor Verification
- Verify the new corporate name: Mast Therapeutics, Inc.
- Confirm the effective date of the name change: March 11, 2013.
- Review the attached press release (Exhibit 99.1) for strategic rationale behind the rebranding.
- Check subsequent filings for updated ticker symbols or trading information.